However, the TSTSS still prognosticated independently of proliferation in multiple independent datasets by multivariate analysis (Table 1), suggesting that the tumor-suppressive effects of TGF-β in ER+ breast cancer must also involve additional biological mechanisms. This evidence concerns the gene TGFB1 and neoplasm.